How to summarize and facilitate the implementation of national and international guidelines in clinical practice? To adress these issues, we present a summary of dyslipidemia management for general practitioners. To achieve these aims, we adopted strategies based on international and national guidelines and focused on clinical applications which implies to choose specific options, such as the use of cardiovascular risk score and specific therapies as first options
Guideline recommendations for the management of dyslipidemia, based on current trial evidence and/or...
Cardiovascular disease (CVD) due to atherosclerosis of the arterial vessel wall and to thrombosis is...
Ischemic heart disease is the leading cause of death worldwide. A disruption to the perfusion and al...
Vicente Giner-Galvañ,1 María José Esteban-Giner,1 Vicente Pallarés-Carra...
After much anticipation, new dyslipidemia guidelines have been published by the American College of ...
SummaryBackgroundScreening for and management of dyslipidaemia are crucial in primary and secondary ...
Dyslipidemia is a major independent risk factor for the development of coronary heart disease, the c...
Dyslipidaemia is a common condition managed in general practice. OBJECTIVE: This article reviews the...
Background information: Dyslipidaemia, the unbalanced level of lipoproteins and triglycerides, contr...
Dyslipidemia is a cardiovascular risk factor that is increasing in prevalence in the country. The ne...
Available from British Library Document Supply Centre- DSC:6219.836(RCGP-OP--55) / BLDSC - British L...
Objective. The implementation of guidelines in clinical practice is still facing a lot of obstacles....
With the growing number of scientific publications, practitioners can use scientific knowledge synth...
La prise en charge du profil lipidique en prévention des maladies cardiovasculaires a évolué au cour...
The identification of modifiable risk factors for coronary heart disease (CHD) and therapies for the...
Guideline recommendations for the management of dyslipidemia, based on current trial evidence and/or...
Cardiovascular disease (CVD) due to atherosclerosis of the arterial vessel wall and to thrombosis is...
Ischemic heart disease is the leading cause of death worldwide. A disruption to the perfusion and al...
Vicente Giner-Galvañ,1 María José Esteban-Giner,1 Vicente Pallarés-Carra...
After much anticipation, new dyslipidemia guidelines have been published by the American College of ...
SummaryBackgroundScreening for and management of dyslipidaemia are crucial in primary and secondary ...
Dyslipidemia is a major independent risk factor for the development of coronary heart disease, the c...
Dyslipidaemia is a common condition managed in general practice. OBJECTIVE: This article reviews the...
Background information: Dyslipidaemia, the unbalanced level of lipoproteins and triglycerides, contr...
Dyslipidemia is a cardiovascular risk factor that is increasing in prevalence in the country. The ne...
Available from British Library Document Supply Centre- DSC:6219.836(RCGP-OP--55) / BLDSC - British L...
Objective. The implementation of guidelines in clinical practice is still facing a lot of obstacles....
With the growing number of scientific publications, practitioners can use scientific knowledge synth...
La prise en charge du profil lipidique en prévention des maladies cardiovasculaires a évolué au cour...
The identification of modifiable risk factors for coronary heart disease (CHD) and therapies for the...
Guideline recommendations for the management of dyslipidemia, based on current trial evidence and/or...
Cardiovascular disease (CVD) due to atherosclerosis of the arterial vessel wall and to thrombosis is...
Ischemic heart disease is the leading cause of death worldwide. A disruption to the perfusion and al...